ORGOVYX cpr pell 120 mg fl 30 pce

7680691500015 CH-69150 L02BX04 07.16.2.
ORGOVYX cpr pell 120 mg fl 30 pce
ORGOVYX cpr pell 120 mg fl 30 pce
ORGOVYX cpr pell 120 mg fl 30 pce
1 / 3
google

Details

Product number
6915001
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
relugolixum 120 mg, mannitolum, carboxymethylamylum natricum A, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, E 171, E 172 (rubrum), cera carnauba, pro compresso obducto corresp. natrium 0.42 - 0.63 mg.

Articles (1)

Orgovyx 120 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
15/08/2025
Professional SmPC
Français
15/08/2025
Professional SmPC
Italien
15/08/2025
Patient information leaflet
Allemand
11/06/2024
Patient information leaflet
Français
11/06/2024
Patient information leaflet
Italien
11/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
120.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 149.95
Specialties list
Yes
Generic
No
SL addition date: 01/01/2024

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
69150
Drug name
Orgovyx, Filmtabletten
Galenic form
FILM
ATC Code
L02BX04
Authorization status
Z
Dispensation category
A
First authorization
17/11/2023
Authorization expiration date
16/11/2028
IT number
07.16.2.
Domain
Human medicine
Field of application
Behandlung von erwachsenen Patienten mit fortgeschrittenem hormonsensitivem Prostatakarzinom.

Packaging details

Description (FR)
ORGOVYX cpr pell 120 mg fl 30 pce
Description (DE)
ORGOVYX Filmtabl 120 mg Fl 30 Stk
Market launch
17/11/2023
Narcotic (BTM)
No